NIIM Research – A/Prof Dr Karin Ried on Movember and the Prostate Cancer Screening Study

Date: 25-11-2020

Movember with A/Prof Dr Karin Ried | NIIM Research

We have an incredible research team at NIIM that collaborate with universities and other medical bodies. Our researchers study the safety and efficacy of integrative medicine and complementary therapies for the prevention, detection and treatment of disease.
In support of Movember, the annual event involving the growth of moustaches during the month of November to raise awareness of men’s health issues such as prostate cancer, testicular cancer and mental illness, our NIIM Research director Associate Professor Dr Karin Ried outlines a prostate cancer screening test for earlier detection developed at NIIM with 97-99% accuracy.
Prostate cancer is the second leading cause of death in Australia. One in seven men likely are diagnosed with prostate cancer in their lifetime. Around 3,300 men die of prostate cancer in Australia each year.

This new non-invasive test allows for early detection of prostate cancer more accurately than the standard PSA blood test. Improving the accuracy of early testing may also help reduce the burden of unnecessary biopsies, and can facilitate earlier intervention.